Achiko AG / Key word(s): Disposal
Achiko Disposes of EmpatKali Holdings and Focuses on Covid-19 Testing Technology
Zurich, 28 August 2020 - Achiko AG (SWX:ACHI, ISIN CH0522213468) is selling its stake in the company EmpatKali. The buyer of EmpatKali is Afterpay, a public listed company. EmpatKali offers a "buy now, pay later" business.
Achiko will receive the initial investment of USD 100,000. The proceeds of the sale of Achiko's holdings will be applied to the development of Gumnuts, Achiko's Covid-19 testing solution in Asia and Europe.
Through innovations in technology and regulation along with the company's unique operating footprint from Europe to Asia, Achiko seeks to transform markets and bring unique value to its customers, people, and shareholders. Achiko's core platform consists of user registration and payment services which are accessible to application developers. A messaging service and other community based social features are being launched in late 2020. Achiko supports innovations in healthcare through its Teman Sehat ("Health Buddy") ecosystem, its Gumnuts novel saliva Covid-19 testing technology based on DNA aptamers developed with Regenacellx.sl, as well as consumer payments and finance and games and entertainment.
Further information about the Teman Sehat ecosystem can be found at https://www.temansehat.co
Further information about Regenacellx.sl can be found at https://regenacellx.com
Further information about Empatkali can be found at https://empatkali.co.id
Investor Relations & Press Contact:
End of ad hoc announcement
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1124485|
|End of Announcement||EQS Group News Service|